Brazil’s federal government tried to alter the label on chloroquine packaging to include a recommendation for its use to treat the Wuhan coronavirus, the country’s former health minister said in an interview with Brazil’s Globo news network, published on Thursday.
The revelation comes as Brazil’s Health Ministry approved new guidelines on Wednesday recommending the widespread use of the anti-malarial drug chloroquine and a less toxic derivative, hydroxychloroquine, to treat coronavirus cases.
Mandetta said members of Brazil’s Attorney General’s Office (AGU), the president of Brazil’s Health Regulatory Agency (ANVISA), and other government ministers were present at the meeting in which President Jair Bolsonaro proposed altering the label on chloroquine packaging for use as a coronavirus treatment, according to the report.
He was replaced by Nelson Teich, who reportedly resigned last week, also over disagreements with the president about expanding the use of chloroquine to treat coronavirus, Agence France-Presse (AFP) reported.
On Wednesday, Teich’s replacement, Interim Health Minister Eduardo Pazuello, signed new hydroxychloroquine guidelines recommending chloroquine and hydroxychloroquine to treat the coronavirus, including mild cases.